These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29145707)

  • 21. Testosterone concentrations in hair of hypogonadal men with and without testosterone replacement therapy.
    Thomson S; Koren G; Van Steen V; Rieder M; Van Uum SH
    Ther Drug Monit; 2009 Dec; 31(6):779-82. PubMed ID: 19809386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.
    Meriggiola MC; Armillotta F; Costantino A; Altieri P; Saad F; Kalhorn T; Perrone AM; Ghi T; Pelusi C; Pelusi G
    J Sex Med; 2008 Oct; 5(10):2442-53. PubMed ID: 18624972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
    Butler GE; Sellar RE; Walker RF; Hendry M; Kelnar CJ; Wu FC
    J Clin Endocrinol Metab; 1992 Jul; 75(1):37-44. PubMed ID: 1619029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva.
    Schönfelder M; Hofmann H; Schulz T; Engl T; Kemper D; Mayr B; Rautenberg C; Oberhoffer R; Thieme D
    Drug Test Anal; 2016 Nov; 8(11-12):1186-1196. PubMed ID: 27723957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of salivary testosterone in adolescents and young men with Duchenne muscular dystrophy.
    Sahun YA; Cheetham T; Boot C; Straub V; Wood CL
    BMC Endocr Disord; 2021 Apr; 21(1):63. PubMed ID: 33838674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of salivary testosterone by liquid chromatography-tandem mass spectrometry: correlation with serum bioavailable testosterone and aging].
    Sakaguchi K; Hasegawa T
    Rinsho Byori; 2005 May; 53(5):388-94. PubMed ID: 15966401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of salivary testosterone by a simple enzyme immunoassay procedure].
    Mita K; Matsubara A; Usui T
    Nihon Hinyokika Gakkai Zasshi; 2005 Sep; 96(6):610-6. PubMed ID: 16218403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).
    Ajo R; Segura A; Mira L; Inda MD; Alfayate R; Sánchez-Barbie A; Margarit C; Peiró AM
    Aging Male; 2017 Mar; 20(1):1-8. PubMed ID: 27750480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal and stress-induced salivary testosterone variation across the menstrual cycle and linkage to motivation and muscle power.
    Cook CJ; Kilduff LP; Crewther BT
    Scand J Med Sci Sports; 2018 Apr; 28(4):1345-1353. PubMed ID: 29266410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease.
    Cardoso EM; Contreras LN; Tumilasci EG; Elbert A; Aguirre EC; Aquilano DR; Arregger AL
    Nephrol Dial Transplant; 2011 Feb; 26(2):677-83. PubMed ID: 20659904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of salivary testosterone as a screening test for male hypogonadism.
    Morley JE; Perry HM; Patrick P; Dollbaum CM; Kells JM
    Aging Male; 2006 Sep; 9(3):165-9. PubMed ID: 17050116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could Testosterone Replacement Therapy in Hypogonadal Men Ameliorate Anemia, a Cardiovascular Risk Factor? An Observational, 54-Week Cumulative Registry Study.
    Zhang LT; Shin YS; Kim JY; Park JK
    J Urol; 2016 Apr; 195(4 Pt 1):1057-64. PubMed ID: 26519655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the salivary testosterone and cortisol concentrations of weightlifters using an enzyme-immunoassay kit.
    Crewther BT; Cook C
    Int J Sports Med; 2010 Jul; 31(7):486-9. PubMed ID: 20419618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
    Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.